<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>cancer therapy outcomes &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/cancer-therapy-outcomes/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 10 Sep 2025 19:44:15 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>cancer therapy outcomes &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Scientists Reveal How COVID-19 Persistence in Cancer Patients Influences Treatment Success</title>
		<link>https://bioengineer.org/scientists-reveal-how-covid-19-persistence-in-cancer-patients-influences-treatment-success/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 10 Sep 2025 19:44:12 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cancer therapy outcomes]]></category>
		<category><![CDATA[COVID-19 persistence in cancer patients]]></category>
		<category><![CDATA[immunocompromised treatment challenges]]></category>
		<category><![CDATA[SARS-CoV-2 gastrointestinal reservoir]]></category>
		<category><![CDATA[SERPINA1 inflammatory biomarker]]></category>
		<guid isPermaLink="false">https://bioengineer.org/scientists-reveal-how-covid-19-persistence-in-cancer-patients-influences-treatment-success/</guid>

					<description><![CDATA[MINNEAPOLIS/ST. PAUL – New findings published by researchers at the University of Minnesota Medical School are shedding light on the perplexing persistence of SARS-CoV-2 in immunocompromised cancer patients, even several weeks after respiratory tests return negative. This groundbreaking research, appearing in the esteemed journal iScience, reveals that the virus continues to reside within the gastrointestinal [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">268488</post-id>	</item>
	</channel>
</rss>
